Peptide handling
5-Amino-1MQ reconstitution calculator
Reconstitution calculator for 5-Amino-1MQ, prefilled for its 50 mg vials. Get the concentration, the dose volume and the U-100 syringe reading.
Start from a compound
Fills the vial size and a starting water volume. Only compounds with a citable range fill a dose.
The second is the question asked once the syringe is already filled, or when checking a vial someone else reconstituted.
1 mg = 1,000 mcg. Published figures are usually micrograms; vial labels are milligrams.
- Draw to
- 15 unitson a U-100 syringe
- Dose
- 2500 mcg
- Dose volume
- 0.15 mL
- Concentration
- 16.667 mg/mL
- Per unit
- 166.67 mcg
- Doses per vial
- 20whole doses; a partial one is not counted
Shown on a 30-unit (0.3 mL) U-100 syringe, the smallest that holds this draw.
5-Amino-1MQ — Animal data only — no human dosing study
Extrapolated from animal studies. No human dosing study exists for this compound, so this range is an inference, not a finding. The prefilled dose is the low end of that range, once daily, after an initial 2-day tolerance dose.
Vial size and water volume are a starting point for the arithmetic, not a recommendation.
Adding more water makes the same dose a larger, easier-to-read mark on the syringe. It does not change how many doses the vial holds.
Vial sizes and starting volume
5-Amino-1MQ is commonly supplied in 50 mg vials. The calculator opens on a 50 mg vial with 3 mL of bacteriostatic water — a starting point for the arithmetic, not a recommendation. Change either and everything recalculates.
That combination gives 16.667 mg/mL, so one insulin unit holds 166.67 mcg and a 2500 mcg dose is 15 units.
What dose to enter
A range of 2500–5000 mcg per dose can be cited for 5-Amino-1MQ, once daily, after an initial 2-day tolerance dose. The dose field opens at the low end of it.
Animal data only — no human dosing study
Extrapolated from animal studies. No human dosing study exists for this compound, so this range is an inference, not a finding.
- ClinicalTrials.gov registry — 5-Amino-1MQ search — ClinicalTrials.gov registry. Registry listing used to check for completed or ongoing human dosing trials; it is a search index, not a dosing study.
- Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunction. — Preclinical mouse study. Mouse study showing NNMT inhibition improves obesity-related metabolic dysfunction — the mechanism this compound's use is built on, not a human dose.
- Development & validation of LC-MS/MS assay for 5-amino-1-methyl quinolinium in rat plasma: Application to pharmacokinetic and oral bioavailability study. — Rat pharmacokinetics study. Establishes rat plasma pharmacokinetics and oral bioavailability, not a human dosing figure.
- Small molecule nicotinamide N-methyltransferase inhibitor activates muscle stem cells and progenitor cell function. — Preclinical mouse study. Mouse study on NNMT inhibition and muscle stem cell activity — mechanistic support, not a dosing study.
- Nicotinamide N-Methyltransferase: More Than a Vitamin B3 Clearance Enzyme. — Preclinical review. Review of NNMT biology providing mechanistic background; establishes no dose.
Related
- 5-Amino-1MQ — the product page, with its current batch.
- Bacteriostatic water — what goes in the vial.
- Peptide reconstitution calculator — the general version, with the blend and half-life calculators alongside it.
- Dosing reference — published schedules, each with the evidence behind it.
For research use only. This tool performs arithmetic on figures you supply — it is not medical guidance and does not recommend a dose for any compound.